The Conversation (0)
The Richmond Club recent released an Investor Presentation highlighting DelMar Pharmaceuticals (OTCQX:DMPI).
The Richmond Club recent released an Investor Presentation highlighting DelMar Pharmaceuticals (OTCQX:DMPI).The company’s lead product candidate, VAL-083, is a first-in-class small molecule chemotherapy with the potential to overcome chemo-resistance in cancer patients and surpass the current standard of care in a range of cancers.
Watch the full video presentation:
Connect with DelMar Pharmaceuticals (OTCQX:DMPI) to receive an Investor Presentation.